Filtered By:
Condition: Autoimmune Disease
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 1104 results found since Jan 2013.
COVID-19 vaccination and liver disease
World J Gastroenterol. 2022 Dec 28;28(48):6791-6810. doi: 10.3748/wjg.v28.i48.6791.ABSTRACTVarious vaccines against severe acute respiratory syndrome coronavirus 2 have been developed in response to the coronavirus disease 2019 (COVID-19) global pandemic, several of which are highly effective in preventing COVID-19 in the general population. Patients with chronic liver diseases (CLDs), particularly those with liver cirrhosis, are considered to be at a high risk for severe COVID-19 and death. Given the increased rates of disease severity and mortality in patients with liver disease, there is an urgent need to understand the...
Source: World Journal of Gastroenterology - January 12, 2023 Category: Gastroenterology Authors: Sotaro Ozaka Takashi Kobayashi Kazuhiro Mizukami Kazunari Murakami Source Type: research
Hypothesis: Viral infections of pregnant women may be early triggers of childhood type 1 diabetes and other autoimmune disease
We present data supporting the use of Rotavirus vaccinations in the reduction of incidence of childhood T1D and propose further investigations into whether other anti-virus vaccinations may reduce the burden of other autoimmune diseases such as multiple sclerosis, atopic dermatitis, psoriasis and subtypes of rheumatoid arthritis, Hashimoto thyroiditis.PMID:36621175 | DOI:10.1016/j.jaut.2022.102977
Source: Journal of Autoimmunity - January 9, 2023 Category: Allergy & Immunology Authors: Zvi Laron Lester Shulman Christiane Hampe Orit Blumenfeld Source Type: research
Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine
Colloids Surf B Biointerfaces. 2022 Dec 20;222:113111. doi: 10.1016/j.colsurfb.2022.113111. Online ahead of print.ABSTRACTThroughout decades, the intrinsic power of the immune system to fight pathogens has inspired researchers to develop techniques that enable the prevention or treatment of infections via boosting the immune response against the target pathogens, which has led to the evolution of vaccines. The recruitment of Lipid nanoparticles (LNPs) as either vaccine delivery platforms or immunogenic modalities has witnessed a breakthrough recently, which has been crowned with the development of effective LNPs-based vacc...
Source: Colloids and Surfaces - December 31, 2022 Category: Biotechnology Authors: Ahmed A H Abdellatif Mahmoud A Younis Abdullah F Alsowinea Emad M Abdallah Mohamed S Abdel-Bakky Amal Al-Subaiyel Yasser A H Hassan Hesham M Tawfeek Source Type: research
Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China
This article is protected by copyright. All rights reserved.PMID:36571260 | DOI:10.1002/jmv.28434
Source: Cancer Control - December 26, 2022 Category: Cancer & Oncology Authors: Hu Li Dachuan Cai Depeng Jiang Xingsheng Li Xiaohui Liao Dongfang Liu Zuojin Liu Peng Zhu Guobing Yin Jia Ming Mingli Peng Min Chen Ning Ling Yinghua Lan Dazhi Zhang Peng Hu Hong Ren Source Type: research
